CTOs on the Move

New York Genome Center

www.nygenome.org

 
The New York Genome Center (NYGC) is at the forefront of transforming biomedical research and clinical care with the mission of saving lives. As a consortium of renowned academic, medical and industry leaders across the globe, NYGC focuses on translating genomic research into clinical solutions for serious disease. Our member organizations are united in this unprecedented collaboration of technology, science, and medicine. We implement advanced genomic research, and integrate our findings with world-class technologies and physician-scientists in order to help solve diseases. We harness the diversity of New York`s institutions and people to drive scientific discoveries that will vastly improve clinical ...
  • Number of Employees: 25-100
  • Annual Revenue: $10-50 Million
  • www.nygenome.org
  • 101 Avenue of the Americas
    New York, NY USA 10013
  • Phone: 646.977.7000

Executives

Name Title Contact Details

Funding

New York Genome Center raised $125M on 05/23/2019

Similar Companies

Expeditor Systems

Expeditor Systems is a Alpharetta, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Mindleap Health

Mindleap is an advanced digital health platform that helps people connect with mental health specialists that can empower them to thrive and develop habits for a healthy mind. Online mental healthcare brings convenience, improves access to treatments and can lead to more personal breakthroughs. Mindleap`s proprietary platform is designed by clinical psychologists and neuroscientists to provide professional support and personalized treatment for every person.

Impact Instrumentation

Impact Instrumentation is a West Caldwell, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Boehringer Ingelheim

For more than 130 years, Boehringer Ingelheim has been committed to the research, development, and manufacturing of new medications with high therapeutic value for people and animals. As a family-owned pharmaceutical company, Boehringer Ingelheim is able to take a long-term view and invest heavily in research and development. We are proud of addressing some of the most challenging healthcare issues. Our vision – value through innovation – has always characterized our collaborative work, and is for us simultaneously a fundamental requirement and a driving force. Headquartered in Ingelheim, Germany, Boehringer Ingelheim operates globally through 145 affiliates and a total of some 47,500 employees.

Emergent Health Corp.

Emergent Health Corp. is a public company (trading under the symbol EMGE) dedicated to the betterment of its shareholders and product consumers. We believe we have a developing product line to become a leader in the field of Regenerative Medicine and improved neutraceuticals and phytonutritionals to be available to the general public without a prescription.